Infectious Disease Alert – January 1, 2009
January 1, 2009
View Issues
-
CD4+ Recovery in HIV-1 Infected Patients is Independent of Class of Antiretroviral Therapy
Patients enrolled in the swiss hiv cohort study, initiating their first cART regimen between 1996 and early 2007, who had baseline and follow up CD4+ count and HIV RNA data available, were included in the analysis. -
Carbapenem-resistant Klebsiella pneumoniae
Most of us microbiologists were rudely awakened to the insufficiency of our susceptibility testing methods last year when the College of American Pathologists (CAP) sent out a carbapenemase-producing Klebsiella pneumoniae as an unknown proficiency testing sample. My laboratory, like most others in the United States, incorrectly reported the isolate as susceptible to imipenem and meropenem. -
Inhaled Antimicrobials in the Treatment of Hospital-acquired Pneumonia
Hospital-acquired pneumonia (HAP) represents the second most common nosocomial infection, accounting for 15% of all hospital-associated infections. -
Updates by Carol Kemper, MD, FACP
An outbreak of 140 human cases of West Nile Virus in Kern County, California (better known for its increased risk of coccidioidomycosis), during the summer of 2007, prompted Reisen et al to look for possible causes. -
Pharmacology Watch: JUPITER: C-reactive Protein a Marker for CV Events?
In this issue: The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions. -
Clinical Briefs in Primary Care supplement